Artal Group Sa increased its stake in Sage Therapeutics Inc (SAGE) by 66.67% based on its latest 2017Q3 regulatory filing with the SEC. Artal Group Sa bought 60,000 shares as the company’s stock rose 0.86% with the market. The institutional investor held 150,000 shares of the health care company at the end of 2017Q3, valued at $9.35M, up from 90,000 at the end of the previous reported quarter. Artal Group Sa who had been investing in Sage Therapeutics Inc for a number of months, seems to be bullish on the $7.67B market cap company. The stock increased 2.02% or $3.32 during the last trading session, reaching $167.47. About 481,849 shares traded. Sage Therapeutics, Inc. (NASDAQ:SAGE) has risen 116.45% since February 27, 2017 and is uptrending. It has outperformed by 99.75% the S&P500.
New South Capital Management Inc increased its stake in Howard Hughes Corp (HHC) by 14.25% based on its latest 2017Q3 regulatory filing with the SEC. New South Capital Management Inc bought 138,773 shares as the company’s stock rose 10.78% with the market. The institutional investor held 1.11 million shares of the real estate investment trusts company at the end of 2017Q3, valued at $131.23 million, up from 973,965 at the end of the previous reported quarter. New South Capital Management Inc who had been investing in Howard Hughes Corp for a number of months, seems to be bullish on the $5.20 billion market cap company. The stock increased 0.68% or $0.83 during the last trading session, reaching $122.51. About 480,019 shares traded or 101.51% up from the average. The Howard Hughes Corporation (NYSE:HHC) has risen 25.50% since February 27, 2017 and is uptrending. It has outperformed by 8.80% the S&P500.
New South Capital Management Inc, which manages about $3.52B and $4.19 billion US Long portfolio, decreased its stake in Corecivic Inc by 82,094 shares to 2.46M shares, valued at $65.85M in 2017Q3, according to the filing. It also reduced its holding in Belmond Ltd (NYSE:BEL) by 386,290 shares in the quarter, leaving it with 3.59M shares, and cut its stake in Shire Plc Adr (NASDAQ:SHPG).
Among 7 analysts covering Howard Hughes (NYSE:HHC), 5 have Buy rating, 1 Sell and 1 Hold. Therefore 71% are positive. Howard Hughes had 11 analyst reports since August 14, 2015 according to SRatingsIntel. Citigroup initiated The Howard Hughes Corporation (NYSE:HHC) rating on Friday, May 13. Citigroup has “Buy” rating and $165 target. The rating was initiated by Sandler O’Neill on Thursday, March 30 with “Hold”. The firm has “Buy” rating given on Monday, May 23 by Compass Point. JMP Securities maintained the stock with “Buy” rating in Sunday, August 16 report. The stock of The Howard Hughes Corporation (NYSE:HHC) earned “Sell” rating by TheStreet on Thursday, September 24. Compass Point maintained The Howard Hughes Corporation (NYSE:HHC) rating on Tuesday, December 8. Compass Point has “Buy” rating and $190 target. The stock has “Buy” rating by BWS Financial on Thursday, June 8. The company was initiated on Monday, October 31 by CJS Securities. The rating was maintained by Citigroup on Wednesday, August 10 with “Buy”.
Since December 29, 2017, it had 0 buys, and 1 insider sale for $319.65 million activity.
Investors sentiment decreased to 1.45 in 2017 Q3. Its down 0.11, from 1.56 in 2017Q2. It dropped, as 20 investors sold HHC shares while 54 reduced holdings. 31 funds opened positions while 76 raised stakes. 35.06 million shares or 1.51% more from 34.54 million shares in 2017Q2 were reported. Quantbot LP invested in 0.01% or 830 shares. Tru Of Vermont stated it has 0.05% in The Howard Hughes Corporation (NYSE:HHC). Highvista Strategies Ltd Llc reported 7,895 shares stake. Cap Research owns 233,575 shares or 0.01% of their US portfolio. Atlantic Tru Grp Ltd Co holds 0% or 1,994 shares in its portfolio. Karpas Strategies Ltd Liability Co holds 10,850 shares or 0.56% of its portfolio. Plante Moran Fincl Advsr Ltd Com reported 63 shares stake. Cibc State Bank Usa has 0.06% invested in The Howard Hughes Corporation (NYSE:HHC). Alliancebernstein Limited Partnership accumulated 20,640 shares or 0% of the stock. Bnp Paribas Arbitrage owns 1,011 shares. Sg Americas Secs Ltd Company reported 1.25 million shares or 1.3% of all its holdings. Alpine Woods Cap Invsts Limited Liability Company holds 0.36% of its portfolio in The Howard Hughes Corporation (NYSE:HHC) for 60,000 shares. Fifth Third Retail Bank owns 150 shares for 0% of their portfolio. D E Shaw And Inc holds 0.03% or 174,447 shares. Ar Asset Management accumulated 4,296 shares.
Among 18 analysts covering SAGE Therapeutics (NASDAQ:SAGE), 16 have Buy rating, 0 Sell and 2 Hold. Therefore 89% are positive. SAGE Therapeutics had 54 analyst reports since September 3, 2015 according to SRatingsIntel. As per Tuesday, September 12, the company rating was maintained by Canaccord Genuity. The rating was initiated by Chardan Capital Markets with “Sell” on Tuesday, May 24. The company was maintained on Friday, August 4 by Canaccord Genuity. BMO Capital Markets maintained Sage Therapeutics, Inc. (NASDAQ:SAGE) rating on Thursday, September 14. BMO Capital Markets has “Outperform” rating and $80 target. Needham maintained Sage Therapeutics, Inc. (NASDAQ:SAGE) rating on Tuesday, June 13. Needham has “Buy” rating and $8200 target. The company was maintained on Thursday, December 7 by SunTrust. On Wednesday, December 14 the stock rating was upgraded by Raymond James to “Strong Buy”. The stock of Sage Therapeutics, Inc. (NASDAQ:SAGE) earned “Outperform” rating by BMO Capital Markets on Wednesday, June 29. Cowen & Co maintained Sage Therapeutics, Inc. (NASDAQ:SAGE) rating on Thursday, August 3. Cowen & Co has “Buy” rating and $10000 target. Stifel Nicolaus maintained it with “Buy” rating and $91.0 target in Tuesday, September 12 report.
Investors sentiment increased to 1.21 in Q3 2017. Its up 0.23, from 0.98 in 2017Q2. It increased, as 33 investors sold SAGE shares while 43 reduced holdings. 28 funds opened positions while 64 raised stakes. 38.55 million shares or 3.62% more from 37.20 million shares in 2017Q2 were reported. Wells Fargo Mn reported 0% stake. Emerald Advisers Pa reported 75,679 shares or 0.19% of all its holdings. Tiaa Cref Mgmt Ltd Llc stated it has 120,514 shares or 0.01% of all its holdings. Great Lakes Advisors Ltd Liability reported 3,853 shares. Invesco reported 108,993 shares stake. Wellington Grp Ltd Liability Partnership holds 0.02% or 1.70 million shares in its portfolio. Proshare Advsrs Ltd Liability Co, Maryland-based fund reported 23,465 shares. Jabre Sa holds 6,000 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 1,378 shares or 0% of its portfolio. Prelude Ltd holds 3,880 shares. The Ohio-based Keybank Association Oh has invested 0% in Sage Therapeutics, Inc. (NASDAQ:SAGE). Thompson Davis invested in 0.03% or 290 shares. Suffolk Mngmt Ltd Limited Liability Company stated it has 0.13% of its portfolio in Sage Therapeutics, Inc. (NASDAQ:SAGE). Tudor Et Al has invested 0.01% in Sage Therapeutics, Inc. (NASDAQ:SAGE). 787,251 are held by Palo Alto Invsts Llc.
The post As Howard Hughes (HHC) Share Price Rose, New South Capital Management Increased Position by $16.24 Million; Artal Group Sa Boosted Sage Therapeutics (SAGE) Position by $3.72 Million appeared first on Stock Market News | HillCountryTimes | Get it Today.
from
https://www.hillcountrytimes.com/2018/02/27/as-howard-hughes-hhc-share-price-rose-new-south-capital-management-increased-position-by-16-24-million-artal-group-sa-boosted-sage-therapeutics-sage-position-by-3-72-million/
No comments:
Post a Comment